Revium Rx cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 4 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Dec2024 | Jun2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | -0.94M | -0.73M | ||
| Share-based CompensationStock Comp. | 4.96M | 0.15M | 4.27M | 3.53M |
| Financing Activities | ||||
| Change in Capital Stock | ||||
| Net Shares Issued and RepurchasedNet Shares Issued | 0.74M | 0.69M |